Topics
January/February 2016 | Special Focus: Inside The Treatment Pipeline
Reversing Retinal Ischemia
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
Logan Christensen, MD, and Jeffrey L. Olson, MD
June 10, 2026
Ethyreal Bio Launches With $101 Million to Advance Potential Disease-Modifying Therapy for TED
AAO Partners with OpenEvidence to Bring Specialty Guidelines Directly Into AI Clinical Workflow
June 9, 2026
Optos Appoints Alexandre Montague as Chief Executive Officer
Heidelberg Engineering Receives FDA Clearance for Enhanced Imaging Software on Spectralis
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
